Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Change in Cash (2016 - 2025)

Historic Change in Cash for Xtant Medical Holdings (XTNT) over the last 17 years, with Q3 2025 value amounting to $3.6 million.

  • Xtant Medical Holdings' Change in Cash rose 12412.94% to $3.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.6 million, marking a year-over-year increase of 31377.03%. This contributed to the annual value of $298000.0 for FY2024, which is 10204.33% up from last year.
  • As of Q3 2025, Xtant Medical Holdings' Change in Cash stood at $3.6 million, which was up 12412.94% from $1.6 million recorded in Q2 2025.
  • Xtant Medical Holdings' 5-year Change in Cash high stood at $16.3 million for Q1 2021, and its period low was -$15.1 million during Q1 2023.
  • In the last 5 years, Xtant Medical Holdings' Change in Cash had a median value of -$124000.0 in 2022 and averaged $436842.1.
  • Its Change in Cash has fluctuated over the past 5 years, first surged by 137929.52% in 2022, then tumbled by 96617.23% in 2023.
  • Quarter analysis of 5 years shows Xtant Medical Holdings' Change in Cash stood at -$227000.0 in 2021, then skyrocketed by 1379.3% to $2.9 million in 2022, then tumbled by 197.31% to -$2.8 million in 2023, then soared by 69.39% to -$865000.0 in 2024, then soared by 516.65% to $3.6 million in 2025.
  • Its last three reported values are $3.6 million in Q3 2025, $1.6 million for Q2 2025, and -$786000.0 during Q1 2025.